Esther Aguilar

Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle.

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.

Cancer cell metabolism as new targets for novel designed therapies.

A key role for transketolase-like 1 in tumor metabolic reprogramming.

Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.

MIDcor, an R-program for deciphering mass interferences in mass spectra of metabolites enriched in stable isotopes.

Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells.

NMDAR Antibodies Alter Dopamine Receptors and Cause Psychotic Behavior in Mice.

Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis.

Placental transfer of NMDAR antibodies causes reversible alterations in mice.

Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice.

Allosteric Modulation of NMDARs Reverses Patients' Autoantibody Effects in Mice.